-
1
-
-
0027255583
-
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
-
Chahinian AP, Antman K, Goutsou M, Corson JM, Suzuki Y, Modeas C, Herndon JE, 2nd, Aisner J, Ellison RR, Leone L, et al.: Randomized phase ii trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the cancer and leukemia group b. J Clin Oncol 1993;11:1559-1565 (Pubitemid 23228263)
-
(1993)
Journal of Clinical Oncology
, vol.11
, Issue.8
, pp. 1559-1565
-
-
Chahinian, A.P.1
Antman, K.2
Goutsou, M.3
Corson, J.M.4
Suzuki, Y.5
Modeas, C.6
Herndon II, J.E.7
Aisner, J.8
Ellison, R.R.9
Leone, L.10
Vogelzang, N.J.11
Green, M.R.12
-
2
-
-
0030248579
-
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: What do we know in the mid-nineties?
-
DOI 10.1016/0959-8049(96)00177-3
-
Bielack SS, Erttmann R, Kempf-Bielack B, Winkler K: Impact of scheduling on toxicity and clinical efficacy of doxorubicin: What do we know in the mid-nineties? Eur J Cancer 1996;32A:1652-1660 (Pubitemid 26306872)
-
(1996)
European Journal of Cancer Part A
, vol.32
, Issue.10
, pp. 1652-1660
-
-
Bielack, S.S.1
Erttmann, R.2
Kempf-Bielack, B.3
Winkler, K.4
-
3
-
-
84869209094
-
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
-
Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET: Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 2012;18:1639-1642
-
(2012)
Nat Med
, vol.18
, pp. 1639-1642
-
-
Zhang, S.1
Liu, X.2
Bawa-Khalfe, T.3
Lu, L.S.4
Lyu, Y.L.5
Liu, L.F.6
Yeh, E.T.7
-
4
-
-
77955891306
-
Acute doxorubicin cardiotoxicity is associated with mir-146a-induced inhibition of the neuregulin-erbb pathway
-
Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasegawa K, Kita T, Kimura T: Acute doxorubicin cardiotoxicity is associated with mir-146a-induced inhibition of the neuregulin-erbb pathway. Cardiovasc Res 2010;87:656-664
-
(2010)
Cardiovasc Res
, vol.87
, pp. 656-664
-
-
Horie, T.1
Ono, K.2
Nishi, H.3
Nagao, K.4
Kinoshita, M.5
Watanabe, S.6
Kuwabara, Y.7
Nakashima, Y.8
Takanabe-Mori, R.9
Nishi, E.10
Hasegawa, K.11
Kita, T.12
Kimura, T.13
-
5
-
-
33644876141
-
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
-
DOI 10.1161/CIRCULATIONAHA.105.576850, PII 0000301720051213000015
-
Wojnowski L, Kulle B, Schirmer M, Schluter G, Schmidt A, Rosenberger A, Vonhof S, Bickeboller H, Toliat MR, Suk EK, Tzvetkov M, Kruger A, Seifert S, Kloess M, Hahn H, Loeffler M, Nurnberg P, Pfreundschuh M, Trumper L, Brockmoller J, Hasenfuss G: Nad(p)h oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 2005;112:3754-3762 (Pubitemid 43739516)
-
(2005)
Circulation
, vol.112
, Issue.24
, pp. 3754-3762
-
-
Wojnowski, L.1
Kulle, B.2
Schirmer, M.3
Schluter, G.4
Schmidt, A.5
Rosenberger, A.6
Vonhof, S.7
Bickeboller, H.8
Toliat, M.R.9
Suk, E.-K.10
Tzvetkov, M.11
Kruger, A.12
Seifert, S.13
Kloess, M.14
Hahn, H.15
Loeffler, M.16
Nurnberg, P.17
Pfreundschuh, M.18
Trumper, L.19
Brockmoller, J.20
Hasenfuss, G.21
more..
-
6
-
-
0035282073
-
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer
-
Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Nair MK, Hoelzer K, Tkaczuk K, Park YC, Lee LW: Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol 2001;19:1444-1454 (Pubitemid 32202552)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.5
, pp. 1444-1454
-
-
Batist, G.1
Ramakrishnan, G.2
Rao, C.S.3
Chandrasekharan, A.4
Gutheil, J.5
Guthrie, T.6
Shah, P.7
Khojasteh, A.8
Nair, M.K.9
Hoelzer, K.10
Tkaczuk, K.11
Youn Choi Park12
Lee, L.W.13
-
7
-
-
0023634395
-
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography
-
Schwartz RG, McKenzie WB, Alexander J, Sager P, D'Souza A, Manatunga A, Schwartz PE, Berger HJ, Setaro J, Surkin L, et al.: Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 1987;82:1109-1118
-
(1987)
Am J Med
, vol.82
, pp. 1109-1118
-
-
Schwartz, R.G.1
McKenzie, W.B.2
Alexander, J.3
Sager, P.4
D'Souza, A.5
Manatunga, A.6
Schwartz, P.E.7
Berger, H.J.8
Setaro, J.9
Surkin, L.10
-
8
-
-
17144405644
-
Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity
-
DOI 10.1161/01.CIR.0000160359.49478.C2
-
Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC: Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 2005;111:1601-1610 (Pubitemid 40525159)
-
(2005)
Circulation
, vol.111
, Issue.13
, pp. 1601-1610
-
-
Fisher, P.W.1
Salloum, F.2
Das, A.3
Hyder, H.4
Kukreja, R.C.5
-
9
-
-
58149343451
-
Heat shock protein 20 interacting with phosphorylated akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity
-
Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, Kranias EG: Heat shock protein 20 interacting with phosphorylated akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity. Circ Res 2008;103:1270-1279
-
(2008)
Circ Res
, vol.103
, pp. 1270-1279
-
-
Fan, G.C.1
Zhou, X.2
Wang, X.3
Song, G.4
Qian, J.5
Nicolaou, P.6
Chen, G.7
Ren, X.8
Kranias, E.G.9
-
10
-
-
31344453935
-
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
-
DOI 10.1016/j.cardiores.2005.08.009, PII S0008636305004256
-
Spallarossa P, Altieri P, Garibaldi S, Ghigliotti G, Barisione C, Manca V, Fabbi P, Ballestrero A, Brunelli C, Barsotti A: Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in h9c2 cells: The role of map kinases and nad(p)h oxidase. Cardiovasc Res 2006;69:736-745 (Pubitemid 43139736)
-
(2006)
Cardiovascular Research
, vol.69
, Issue.3
, pp. 736-745
-
-
Spallarossa, P.1
Altieri, P.2
Garibaldi, S.3
Ghigliotti, G.4
Barisione, C.5
Manca, V.6
Fabbi, P.7
Ballestrero, A.8
Brunelli, C.9
Barsotti, A.10
-
11
-
-
41749103345
-
2 /M phase cell cycle arrest
-
DOI 10.1152/ajpheart.91507.2007
-
Venkatakrishnan CD, Dunsmore K, Wong H, Roy S, Sen CK, Wani A, Zweier JL, Ilangovan G: Hsp27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac h9c2 cells: P21 upregulation and g2/m phase cell cycle arrest. Am J Physiol Heart Circ Physiol 2008;294:H1736-1744 (Pubitemid 351490604)
-
(2008)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.294
, Issue.4
-
-
Venkatakrishnan, C.D.1
Dunsmore, K.2
Wong, H.3
Roy, S.4
Sen, C.K.5
Wani, A.6
Zweier, J.L.7
Ilangovan, G.8
-
12
-
-
73649099845
-
Transcription factor gata4 inhibits doxorubicin-induced autophagy and cardiomyocyte death
-
Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q: Transcription factor gata4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem 2010;285:793-804
-
(2010)
J Biol Chem
, vol.285
, pp. 793-804
-
-
Kobayashi, S.1
Volden, P.2
Timm, D.3
Mao, K.4
Xu, X.5
Liang, Q.6
-
13
-
-
19944432052
-
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model
-
DOI 10.1161/01.CIR.0000151812.86142.45
-
Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC: Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005;111:150-156 (Pubitemid 40139725)
-
(2005)
Circulation
, vol.111
, Issue.2
, pp. 150-156
-
-
Silva, G.V.1
Litovsky, S.2
Assad, J.A.R.3
Sousa, A.L.S.4
Martin, B.J.5
Vela, D.6
Coulter, S.C.7
Lin, J.8
Ober, J.9
Vaughn, W.K.10
Branco, R.V.C.11
Oliveira, E.M.12
He, R.13
Geng, Y.-J.14
Willerson, J.T.15
Perin, E.C.16
-
14
-
-
0036142213
-
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart
-
DOI 10.1161/hc0102.101442
-
Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD: Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98 (Pubitemid 34049148)
-
(2002)
Circulation
, vol.105
, Issue.1
, pp. 93-98
-
-
Toma, C.1
Pittenger, M.F.2
Cahill, K.S.3
Byrne, B.J.4
Kessler, P.D.5
-
15
-
-
33846395496
-
In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function
-
DOI 10.1016/j.yjmcc.2006.10.009, PII S0022282806009643
-
Xu M, Uemura R, Dai Y, Wang Y, Pasha Z, Ashraf M: In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 2007;42:441-448 (Pubitemid 46135600)
-
(2007)
Journal of Molecular and Cellular Cardiology
, vol.42
, Issue.2
, pp. 441-448
-
-
Xu, M.1
Uemura, R.2
Dai, Y.3
Wang, Y.4
Pasha, Z.5
Ashraf, M.6
-
16
-
-
0041431109
-
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution
-
DOI 10.1161/01.CIR.0000084828.50310.6A
-
Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation 2003;108:863-868 (Pubitemid 37022130)
-
(2003)
Circulation
, vol.108
, Issue.7
, pp. 863-868
-
-
Barbash, I.M.1
Chouraqui, P.2
Baron, J.3
Feinberg, M.S.4
Etzion, S.5
Tessone, A.6
Miller, L.7
Guetta, E.8
Zipori, D.9
Kedes, L.H.10
Kloner, R.A.11
Leor, J.12
-
17
-
-
67649121808
-
Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart
-
Khan M, Meduru S, Mohan IK, Kuppusamy ML, Wisel S, Kulkarni A, Rivera BK, Hamlin RL, Kuppusamy P: Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol 2009;47:275-287
-
(2009)
J Mol Cell Cardiol
, vol.47
, pp. 275-287
-
-
Khan, M.1
Meduru, S.2
Mohan, I.K.3
Kuppusamy, M.L.4
Wisel, S.5
Kulkarni, A.6
Rivera, B.K.7
Hamlin, R.L.8
Kuppusamy, P.9
-
18
-
-
67349123886
-
Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes
-
Benzhi C, Limei Z, Ning W, Jiaqi L, Songling Z, Fanyu M, Hongyu Z, Yanjie L, Jing A, Baofeng Y: Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. J Mol Cell Cardiol 2009;47:41-48
-
(2009)
J Mol Cell Cardiol
, vol.47
, pp. 41-48
-
-
Benzhi, C.1
Limei, Z.2
Ning, W.3
Jiaqi, L.4
Songling, Z.5
Fanyu, M.6
Hongyu, Z.7
Yanjie, L.8
Jing, A.9
Baofeng, Y.10
-
19
-
-
84877108953
-
Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating jnk signal
-
Cai B, Li X, Wang Y, Liu Y, Yang F, Chen H, Yin K, Tan X, Zhu J, Pan Z, Wang B, Lu Y: Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating jnk signal. PLoS One 2013;8:e63561
-
(2013)
PLoS One
, vol.8
-
-
Cai, B.1
Li, X.2
Wang, Y.3
Liu, Y.4
Yang, F.5
Chen, H.6
Yin, K.7
Tan, X.8
Zhu, J.9
Pan, Z.10
Wang, B.11
Lu, Y.12
-
20
-
-
76749106496
-
Arsenic trioxide induces the apoptosis in bone marrow mesenchymal stem cells by intracellular calcium signal and caspase-3 pathways
-
Cai BZ, Meng FY, Zhu SL, Zhao J, Liu JQ, Liu CJ, Chen N, Ye ML, Li ZY, Ai J, Lu YJ, Yang BF: Arsenic trioxide induces the apoptosis in bone marrow mesenchymal stem cells by intracellular calcium signal and caspase-3 pathways. Toxicol Lett 2010;193:173-178
-
(2010)
Toxicol Lett
, vol.193
, pp. 173-178
-
-
Cai, B.Z.1
Meng, F.Y.2
Zhu, S.L.3
Zhao, J.4
Liu, J.Q.5
Liu, C.J.6
Chen, N.7
Ye, M.L.8
Li, Z.Y.9
Ai, J.10
Lu, Y.J.11
Yang, B.F.12
-
21
-
-
79955753803
-
The protective role of arjunolic acid against doxorubicin induced intracellular ros dependent jnk-p38 and p53-mediated cardiac apoptosis
-
Ghosh J, Das J, Manna P, Sil PC: The protective role of arjunolic acid against doxorubicin induced intracellular ros dependent jnk-p38 and p53-mediated cardiac apoptosis. Biomaterials 2011;32:4857-4866
-
(2011)
Biomaterials
, vol.32
, pp. 4857-4866
-
-
Ghosh, J.1
Das, J.2
Manna, P.3
Sil, P.C.4
-
22
-
-
0042697468
-
The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide
-
DOI 10.1016/S0006-2952(03)00255-7
-
Brantley-Finley C, Lyle CS, Du L, Goodwin ME, Hall T, Szwedo D, Kaushal GP, Chambers TC: The jnk, erk and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol 2003;66:459-469 (Pubitemid 36937031)
-
(2003)
Biochemical Pharmacology
, vol.66
, Issue.3
, pp. 459-469
-
-
Brantley-Finley, C.1
Lyle, C.S.2
Du, L.3
Goodwin, M.E.4
Hall, T.5
Szwedo, D.6
Kaushal, G.P.7
Chambers, T.C.8
-
23
-
-
0037032817
-
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
-
DOI 10.1126/science.1072682
-
Johnson GL, Lapadat R: Mitogen-Activated protein kinase pathways mediated by erk, jnk, and p38 protein kinases. Science 2002;298:1911-1912 (Pubitemid 35425238)
-
(2002)
Science
, vol.298
, Issue.5600
, pp. 1911-1912
-
-
Johnson, G.L.1
Lapadat, R.2
-
24
-
-
0028880006
-
Opposing effects of erk and jnk-p38 map kinases on apoptosis
-
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of erk and jnk-p38 map kinases on apoptosis. Science 1995;270:1326-1331
-
(1995)
Science
, vol.270
, pp. 1326-1331
-
-
Xia, Z.1
Dickens, M.2
Raingeaud, J.3
Davis, R.J.4
Greenberg, M.E.5
-
25
-
-
33947381796
-
Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione
-
Fan Y, Chen H, Qiao B, Luo L, Ma H, Li H, Jiang J, Niu D, Yin Z: Opposing effects of erk and p38 map kinases on hela cell apoptosis induced by dipyrithione. Mol Cells 2007;23:30-38 (Pubitemid 46443895)
-
(2007)
Molecules and Cells
, vol.23
, Issue.1
, pp. 30-38
-
-
Fan, Y.1
Chen, H.2
Qiao, B.3
Luo, L.4
Ma, H.5
Li, H.6
Jiang, J.7
Niu, D.8
Yin, Z.9
-
26
-
-
79952575620
-
Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of pi3-k/akt and inhibition of p53, p38-jnk
-
Das J, Ghosh J, Manna P, Sil PC: Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of pi3-k/akt and inhibition of p53, p38-jnk. Biochem Pharmacol 2011;81:891-909
-
(2011)
Biochem Pharmacol
, vol.81
, pp. 891-909
-
-
Das, J.1
Ghosh, J.2
Manna, P.3
Sil, P.C.4
-
27
-
-
44649141966
-
Regulation of autophagy by cytoplasmic p53
-
DOI 10.1038/ncb1730, PII NCB1730
-
Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, Nannmark U, Samara C, Pinton P, Vicencio JM, Carnuccio R, Moll UM, Madeo F, Paterlini-Brechot P, Rizzuto R, Szabadkai G, Pierron G, Blomgren K, Tavernarakis N, Codogno P, Cecconi F, Kroemer G: Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008;10:676-687 (Pubitemid 351772933)
-
(2008)
Nature Cell Biology
, vol.10
, Issue.6
, pp. 676-687
-
-
Tasdemir, E.1
Maiuri, M.C.2
Galluzzi, L.3
Vitale, I.4
Djavaheri-Mergny, M.5
D'Amelio, M.6
Criollo, A.7
Morselli, E.8
Zhu, C.9
Harper, F.10
Nannmark, U.11
Samara, C.12
Pinton, P.13
Vicencio, J.M.14
Carnuccio, R.15
Moll, U.M.16
Madeo, F.17
Paterlini-Brechot, P.18
Rizzuto, R.19
Szabadkai, G.20
Pierron, G.21
Blomgren, K.22
Tavernarakis, N.23
Codogno, P.24
Cecconi, F.25
Kroemer, G.26
more..
-
28
-
-
2942616456
-
2 - and p53-dependent pathways
-
DOI 10.1074/jbc.M400944200
-
Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B: Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H2O2-and p53-dependent pathways. J Biol Chem 2004;279:25535-25543 (Pubitemid 38756813)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.24
, pp. 25535-25543
-
-
Wang, S.1
Konorev, E.A.2
Kotamraju, S.3
Joseph, J.4
Kalivendi, S.5
Kalyanaraman, B.6
-
29
-
-
0037041392
-
P63 and p73 are required for p53-dependent apoptosis in response to DNA damage
-
DOI 10.1038/416560a
-
Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T: P63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002;416:560-564 (Pubitemid 34288861)
-
(2002)
Nature
, vol.416
, Issue.6880
, pp. 560-564
-
-
Flores, E.R.1
Tsai, K.Y.2
Crowley, D.3
Sengupta, S.4
Yang, A.5
McKeon, F.6
Jacks, T.7
-
30
-
-
33746364197
-
Bcl-2 phosphorylation by p38 MAPK: Identification of target sites and biologic consequences
-
DOI 10.1074/jbc.M511052200
-
De Chiara G, Marcocci ME, Torcia M, Lucibello M, Rosini P, Bonini P, Higashimoto Y, Damonte G, Armirotti A, Amodei S, Palamara AT, Russo T, Garaci E, Cozzolino F: Bcl-2 phosphorylation by p38 mapk: Identification of target sites and biologic consequences. J Biol Chem 2006;281:21353-21361 (Pubitemid 44115474)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.30
, pp. 21353-21361
-
-
De Chiara, G.1
Marcocci, M.E.2
Torcia, M.3
Lucibello, M.4
Rosini, P.5
Bonini, P.6
Higashimoto, Y.7
Damonte, G.8
Armirotti, A.9
Amodei, S.10
Palamara, A.T.11
Russo, T.12
Garaci, E.13
Cozzolino, F.14
-
31
-
-
0034383398
-
P53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 mapk-p53 signaling in response to uv radiation
-
Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, Taya Y, Imai K: P53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 mapk-p53 signaling in response to uv radiation. EMBO J 2000;19:6517-6526
-
(2000)
EMBO J
, vol.19
, pp. 6517-6526
-
-
Takekawa, M.1
Adachi, M.2
Nakahata, A.3
Nakayama, I.4
Itoh, F.5
Tsukuda, H.6
Taya, Y.7
Imai, K.8
-
32
-
-
15044342095
-
Phosphorylation-dependent degradation of p300 by doxorubicin-Activated p38 mitogen-Activated protein kinase in cardiac cells
-
Poizat C, Puri PL, Bai Y, Kedes L: Phosphorylation-dependent degradation of p300 by doxorubicin-Activated p38 mitogen-Activated protein kinase in cardiac cells. Mol Cell Biol 2005;25:2673-2687.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 2673-2673
-
-
Poizat, C.1
Puri, P.L.2
Bai, Y.3
Kedes, L.4
|